According to FutureWise analysis, the market for synthetic stem cells is projected to expand at a CAGR of 22.5% from 2023-2031.
The research related to cardiac stem cells (CSCs) is on a rise owing to increasing incidences of various cardiovascular diseases worldwide. Growing emphasis on engineering niche to synthetic stem cells has accelerated the market growth significantly. The generalization of technology to different stem cell types and better preservation stability has led to such kind of research gaining importance in the market. Furthermore, there has been a rise in stem-cell targeted therapies in neurology and cardiology for research activities which has increased the market demand. Synthetic stem cells are capable of bypassing immune systems and they also allow flexibility in manufacturing processes which further bolsters the market growth.